Shokoufeh Hajsadeghi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shokoufeh Hajsadeghi has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Maral Hejrati
Rasoul-e-Akram Hospital, Iran University of Medical Sciences, Tehran, Iran
2 shared publications- Mir Farhad Ghalehbandi
Sleep Medicine Fellowship, Mental Health Research Center, Department of Psychiatry, School of Medicine Iran University of Medical Sciences Tehran Iran
1 shared publication Roozbeh Naghshin
Rasoul-e-Akram Hospital, Iran University of Medical Sciences, Tehran, Iran
1 shared publicationScott Reza Jafarian Kerman
Tehran University of Medical Sciences, Tehran, Iran
1 shared publication- Seyed Hashem Sezavar
Research Center for Prevention of Cardiovascular Disease, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran
1 shared publication
Latest Publications
- Open Access
- 13 January 2016
- Vol. 11 (1) , 11-14
Left Ventricular Mass Index and Pulmonary Artery Pressure in Patients with the Obstructive Sleep Apnea Syndrome
Background: Sleep apnea is accompanied by some cardiovascular complications. It has even been hypothesized that sleep apnea, itself, can induce some of these complications. Given such controversies, we assessed the left ventricular mass index (LVMI) and systolic pulmonary artery pressure in patients with sleep apnea.
- 13 January 2016
- Vol. 11 (1) , 11-14
Open AccessLeft Ventricular Mass Index and Pulmonary Artery Pressure in Patients with the Obstructive Sleep Apnea Syndrome
Background: Sleep apnea is accompanied by some cardiovascular complications. It has even been hypothesized that sleep apnea, itself, can induce some of these complications. Given such controversies, we assessed the left ventricular mass index (LVMI) and systolic pulmonary artery pressure in patients with sleep apnea.
- Open Access
- 8 January 2015
- Vol. 10 (1) , 46-49
Right Ventricular Thrombus in a 36-Year-Old Man with Factor V Leiden
Factor V Leiden deficiency is the most common hereditary hypercoagulable disease in the United States and involves 5% of the Caucasian population. Up to 30% of patients who present with deep vein thrombosis (DVT) or pulmonary thromboembolism present with this condition. This is a case report of a 36-year-old man who experienced one episode of DVT within the previous year and was admitted to our hospital due to productive coughs and hemoptysis. Paraclinical studies demonstrated a right ventricular thrombus. Additional investigation was done to find the underlying cause. Laboratory tests were positive for Factor V Leiden mutation. Other factors for hypercoagulability states were normal. Given that Factor V Leiden mutation is a life-threatening condition with a relatively high prevalence and considering its thrombogenesis, screening tests are necessary in young patients without obvious reasons for recurrent thrombus formation. It seems that medical noninvasive treatments can be an alternative therapy to surgery when a ventricular thrombus is suspected in these patients.
- 8 January 2015
- Vol. 10 (1) , 46-49
Open AccessRight Ventricular Thrombus in a 36-Year-Old Man with Factor V Leiden
Factor V Leiden deficiency is the most common hereditary hypercoagulable disease in the United States and involves 5% of the Caucasian population. Up to 30% of patients who present with deep vein thrombosis (DVT) or pulmonary thromboembolism present with this condition. This is a case report of a 36-year-old man who experienced one episode of DVT within the previous year and was admitted to our hospital due to productive coughs and hemoptysis. Paraclinical studies demonstrated a right ventricular thrombus. Additional investigation was done to find the underlying cause. Laboratory tests were positive for Factor V Leiden mutation. Other factors for hypercoagulability states were normal. Given that Factor V Leiden mutation is a life-threatening condition with a relatively high prevalence and considering its thrombogenesis, screening tests are necessary in young patients without obvious reasons for recurrent thrombus formation. It seems that medical noninvasive treatments can be an alternative therapy to surgery when a ventricular thrombus is suspected in these patients.